Inactive Instrument
Medicure Inc Share Price Toronto S.E.
Stocks
MPH
CA58469E4085
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 11.17M 7.97M 6.97M 6.43M 5.92M 768M 11.41M 76.83M 30.22M 376M 29.93M 29.28M 1.29B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 8.22M 5.87M 5.13M 4.73M 4.36M 565M 8.41M 56.57M 22.25M 277M 22.04M 21.56M 953M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
72.7% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Medicure Inc
| 1 day | -5.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 14/09/1997 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 31/05/2022 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 14/09/1997 |
Arnold Naimark
BRD | Director/Board Member | 92 | 27/02/2000 |
Brent Fawkes
BRD | Director/Board Member | 56 | 21/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.23% | +0.16% | - | - | 7.97M | ||
| -0.74% | -1.71% | +54.58% | +55.93% | 53.83B | ||
| -7.17% | -4.39% | +42.72% | +73.70% | 52.1B | ||
| +0.80% | -6.31% | +5.62% | +413.12% | 23.48B | ||
| -0.09% | -0.01% | -16.85% | -16.17% | 23.13B | ||
| +3.46% | +2.52% | +36.64% | -5.41% | 19.36B | ||
| +0.03% | -1.73% | +34.42% | -32.45% | 17.56B | ||
| -5.16% | -7.00% | +168.44% | +291.24% | 15.2B | ||
| +3.62% | 0.00% | +33.47% | +643.91% | 14.83B | ||
| +0.43% | -1.03% | +25.75% | +186.18% | 14.06B | ||
| Average | -1.00% | -2.62% | +42.76% | +178.89% | 25.95B | |
| Weighted average by Cap. | -1.48% | -2.36% | +41.27% | +137.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.64M 13.66M 12.61M 11.62M 1.51B 22.39M 151M 59.28M 737M 58.72M 57.44M 2.54B | 28.86M 20.6M 18M 16.61M 15.31M 1.98B 29.5M 199M 78.08M 971M 77.35M 75.65M 3.34B |
| Net income | -1.04M -742K -648K -598K -551K -71.42M -1.06M -7.15M -2.81M -34.98M -2.79M -2.72M -120M | -7.1M -5.07M -4.43M -4.09M -3.77M -488M -7.25M -48.83M -19.2M -239M -19.02M -18.61M -822M |
| Net Debt | -6.32M -4.51M -3.94M -3.64M -3.35M -434M -6.46M -43.46M -17.09M -213M -16.93M -16.56M -732M | -2.94M -2.1M -1.84M -1.69M -1.56M -202M -3.01M -20.25M -7.97M -99.11M -7.89M -7.72M -341M |
Employees
-

















